Some older adults with diabetes overtreated for their disease
the ONA take:
According to a new study published in JAMA Internal Medicine, many older adults with diabetes are being overtreated for their disease.
For the study, researchers from Yale University School of Medicine in New Haven, Connecticut, identified nearly 1,300 adults aged 65 years and older with diabetes from the National Health and Nutrition Examination Survey (NHANES) and separated them into three cohorts depending on their state of health: relatively healthy, complex/intermediate health, and very complex/poor health.
Results showed that among all participants, 61.5% had tight glycemic control, which was defined as an A1C less than 7%. In the relatively healthy group, 62.8% had tight glycemic control compared with 63% of those in the complex/intermediate health group and 56.4% of those in the very complex/poor health group.
In addition, about 55% of patients were treated with either sulfonylureas or insulin. Although the American Diabetes Association recommends an A1C level less than 7% among patients with diabetes, older patients are more susceptible to hypoglycemia and may benefit less from such tight glycemic control.
Those with diabetes in complex/intermediate or very complex/poor health are at a higher risk of treatment-related harms and less likely to derive benefit from intensive glycemic control.
Many older adults with diabetes are being overtreated for their disease.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|